Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

596 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of prior treatment on patients with relapsed multiple myeloma treated with carfilzomib and dexamethasone vs bortezomib and dexamethasone in the phase 3 ENDEAVOR study.
Moreau P, Joshua D, Chng WJ, Palumbo A, Goldschmidt H, Hájek R, Facon T, Ludwig H, Pour L, Niesvizky R, Oriol A, Rosiñol L, Suvorov A, Gaidano G, Pika T, Weisel K, Goranova-Marinova V, Gillenwater HH, Mohamed N, Aggarwal S, Feng S, Dimopoulos MA. Moreau P, et al. Among authors: hajek r. Leukemia. 2017 Jan;31(1):115-122. doi: 10.1038/leu.2016.186. Epub 2016 Jul 4. Leukemia. 2017. PMID: 27491641 Free PMC article. Clinical Trial.
Therapy of anemia in patients with multiple myeloma.
Adam Z, Krahulová M, Spelda S, Vorlícek J, Hejlová N, Hájek R, Tomíska M. Adam Z, et al. Among authors: hajek r. Acta Med Austriaca. 1995;22(4):59-64. Acta Med Austriaca. 1995. PMID: 8835422
Current role of immunotherapy in multiple myeloma.
Hájek R, Adam Z, Krivanová A, Doubek M, Korístek Z, Vorlícek J. Hájek R, et al. Acta Med Austriaca. 1998;25(3):79-85. Acta Med Austriaca. 1998. PMID: 9816399 Review.
[Quality of life and tolerance of maintenance therapy in patients with multiple myeloma].
Adam Z, Pour L, Svobodník A, Scudla V, Salajka F, Vytrasová M, Bacovský J, Schützová M, Koza V, Sumná E, Franková H, Lehanka F, Gumulec J, Stavarová Y, Cahová S, Vránová M, Dostálová V, Kessler P, Walterová L, Meluzínová I, Seifertová N, Sláma O, Büchler T, Krejcí M, Bencíková V, Nykodýmová V, Dusek L, Hájek R; Czech Myeloma Group. Adam Z, et al. Among authors: hajek r. Vnitr Lek. 2002 Mar;48(3):216-29. Vnitr Lek. 2002. PMID: 11968583 Clinical Trial. Czech.
Second autologous transplantation for multiple myeloma patients relapsing after the first autograft -- a pilot study for the evaluation of experimental maintenance therapies. Report of the prospective non-randomized pilot study of the Czech Myeloma Group.
Krivanová A, Hájek R, Krejcí M, Scudla V, Indrák K, Bacovský J, Büchler T, Svobodník A, Adam Z, Mayer J, Vorlícek J; Czech Myeloma Group. Krivanová A, et al. Among authors: hajek r. Onkologie. 2004 Jun;27(3):275-9. doi: 10.1159/000077977. Onkologie. 2004. PMID: 15249717 Clinical Trial.
Skin lesions induced by bortezomib.
Pour L, Hajek R, Zdenek A, Krejci M, Krivanova A, Vorlicek J. Pour L, et al. Among authors: hajek r. Haematologica. 2005 Dec;90(12 Suppl):ECR44. Haematologica. 2005. PMID: 16464759
596 results